Technical analysis of Gelteq Limited Ordinary Shares (GELS): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Price Performance
| 1 month | +9.16% |
| 3 months | -44.21% |
| Year-to-date | -27.47% |
| 1 year | -62.32% |
52-Week Range
| 52-week High | $2.01 |
| 52-week Low | $0.39 |
| Avg Volume (90d) | 4.2M |
Technical Indicators
| SMA 50 | $0.61 |
| SMA 200 | $0.73 |
| Beta | 0.04 |
| 30-day Volatility (annualised) | 165.3% |
| Price vs SMA 50 | -4.3% |
| Price vs SMA 200 | -20.5% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.18 | |
| 2025-11 | $1.08 | -8.5% |
| 2025-12 | $0.80 | -25.9% |
| 2026-01 | $0.97 | +21.3% |
| 2026-02 | $0.76 | -22.0% |
| 2026-03 | $0.66 | -12.6% |
| 2026-04 | $0.65 | -2.4% |
| 2026-05 | $0.49 | -24.2% |
| 2026-06 | $0.67 | +37.0% |
| 2026-07 | $0.52 | -22.4% |
| 2026-08 | $0.55 | +4.9% |
| 2026-09 | $0.58 | +6.3% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $0.58 |
| Market Cap | $5M |
| Exchange | NASDAQ |
| Country | AU |
Valuation Ratios
| Price / Book | 0.59 |
| EV / EBITDA | -5.67 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.36 |
| Current Ratio | 0.09 |